T1	Participants 325 390	prospective French study comparing four doses of immunoglobulins.
T2	Participants 407 452	hematopoietic stem-cell transplant recipients
T3	Participants 1531 1554	Diagnosis Related Group
T4	Participants 1442 1471	homogeneous group of patients
